---
figid: PMC7198187__gr1_lrg
figlink: pmc/articles/PMC7198187/figure/fig1/
number: F1
caption: 'SARS-CoV-2 interaction with the inflammatory system and therapy targets
  within the systemTLR4, AT1R, IL-6, IL-1, IL-18, type 1 IFNs, and IFN-γ receptor
  binding activates specific signalling cascades and translocation of nuclear transcription
  factors into the nucleus (blue ellipse), where they interact with their respective
  chaperones (NF-KB) or their targeting sequences on DNA (ISRE, GAS) to activate the
  production of multiple proteins including additional cytokines, chemokines, cell
  surface molecules, and more. SARS-CoV-2 also directly interacts with ACE2 (via S
  protein) causing uninhibited Ang II activation of AT1R while also decreasing TLR4
  inhibition; in addition, SARS-CoV-2 inhibits TYK 2 (vis NSP1), further driving inflammation
  by causing downstream effects that overlap with the immunomodulatory pathway. Anticytokine,
  JAK inhibitors, and antihypertensives can limit hyperinflammation by interacting
  and inhibiting these signalling cascades. ACE=angiotensin converting enzyme. Ang=angiotensin.
  ATR1=type 1 angiotensin II receptor. AT2R=type 2 angiotensin II receptor. COX=cyclooxygenase.
  GAS=IFN-γ activation site. ICAM=intercellular adhesion molecule. IL=interleukin.
  IFN=interferon. IRF=IFN regulatory factor. ISG=IFN-stimulated gene. ISRE=IFN-stimulated
  response element. JAK=Janus kinase. MCP=monocyte chemoattractant protein. NSP=non-structural
  protein. PD-1=programmed cell death 1. R=receptor. SARS-CoV-2=severe acute respiratory
  syndrome coronavirus 2. TGF=transforming growth factor. TLR=toll-like receptor.
  TNF=tumour necrosis factor. TRIF=TIR-domain-containing adapter-inducing interferon-β.
  TXA=thromboxane. TYK=tyrosine kinase. VEGF=vascular endothelial growth factor. *JAK
  inhibitors: ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and
  upadacitinib.'
pmcid: PMC7198187
papertitle: Immunomodulation in COVID-19.
reftext: Nicholas E Ingraham, et al. Lancet Respir Med. 2020 Jun;8(6):544-546.
pmc_ranked_result_index: '29444'
pathway_score: 0.9372713
filename: gr1_lrg.jpg
figtitle: Immunomodulation in COVID-19
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7198187__gr1_lrg.html
  '@type': Dataset
  description: 'SARS-CoV-2 interaction with the inflammatory system and therapy targets
    within the systemTLR4, AT1R, IL-6, IL-1, IL-18, type 1 IFNs, and IFN-γ receptor
    binding activates specific signalling cascades and translocation of nuclear transcription
    factors into the nucleus (blue ellipse), where they interact with their respective
    chaperones (NF-KB) or their targeting sequences on DNA (ISRE, GAS) to activate
    the production of multiple proteins including additional cytokines, chemokines,
    cell surface molecules, and more. SARS-CoV-2 also directly interacts with ACE2
    (via S protein) causing uninhibited Ang II activation of AT1R while also decreasing
    TLR4 inhibition; in addition, SARS-CoV-2 inhibits TYK 2 (vis NSP1), further driving
    inflammation by causing downstream effects that overlap with the immunomodulatory
    pathway. Anticytokine, JAK inhibitors, and antihypertensives can limit hyperinflammation
    by interacting and inhibiting these signalling cascades. ACE=angiotensin converting
    enzyme. Ang=angiotensin. ATR1=type 1 angiotensin II receptor. AT2R=type 2 angiotensin
    II receptor. COX=cyclooxygenase. GAS=IFN-γ activation site. ICAM=intercellular
    adhesion molecule. IL=interleukin. IFN=interferon. IRF=IFN regulatory factor.
    ISG=IFN-stimulated gene. ISRE=IFN-stimulated response element. JAK=Janus kinase.
    MCP=monocyte chemoattractant protein. NSP=non-structural protein. PD-1=programmed
    cell death 1. R=receptor. SARS-CoV-2=severe acute respiratory syndrome coronavirus
    2. TGF=transforming growth factor. TLR=toll-like receptor. TNF=tumour necrosis
    factor. TRIF=TIR-domain-containing adapter-inducing interferon-β. TXA=thromboxane.
    TYK=tyrosine kinase. VEGF=vascular endothelial growth factor. *JAK inhibitors:
    ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and upadacitinib.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1A
  - IL1B
  - IL6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ACE
  - ACE2
  - IRF4
  - PRDM1
  - TIGIT
  - TLR4
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - ICAM1
  - CCL2
  - IL12A
  - IL12B
  - TNF
  - IL18
  - CXCL8
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - IL1R1
  - MYD88
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - SH2D3A
  - AR
  - IRF9
  - STAT2
  - PDCD1
  - IFNB1
  - STAT1
  - STAT3
  - IL6R
  - TGFB1
  - TGFB2
  - TGFB3
  - GAST
  - Losartan
  - Enalapril
  - captopril
  - TXA
  - SARS-COV-2
genes:
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ACE1
  symbol: ACE1
  source: hgnc_alias_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: -ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: IRF-4
  symbol: IRF4
  source: hgnc_symbol
  hgnc_symbol: IRF4
  entrez: '3662'
- word: Blimp1
  symbol: BLIMP1
  source: hgnc_prev_symbol
  hgnc_symbol: PRDM1
  entrez: '639'
- word: TIGIT
  symbol: TIGIT
  source: hgnc_symbol
  hgnc_symbol: TIGIT
  entrez: '201633'
- word: TLR4-
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: MCP-1/CCL2
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: MCP-1/CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: TNFA
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6,IL-8,IL-18,TNFA
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-6,IL-8,IL-18,TNFA
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6,IL-8,IL-18,TNFA
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,IL-8,IL-18,TNFA
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IL-1R/IL-18R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IL-1/IL-18-
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1/IL-18-
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1/IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-1/IL-18
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1/IL-18
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NF-KB-
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB-
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB-
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB-
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB-
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: NSP1
  symbol: NSP1
  source: hgnc_alias_symbol
  hgnc_symbol: SH2D3A
  entrez: '10045'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFN-a/AIFN-a/AR-
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: 'IRF-9:'
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: STAT2/-
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT2/-
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: IFN-a/B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IL-6-
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Complement,IL-6,VEGF,cyclinD1,TNF¤,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNF¤,
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TGF-B,ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT1/
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: GAS
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
chemicals:
- word: Losartan
  source: MESH
  identifier: D019808
- word: Enalapril
  source: MESH
  identifier: D004656
- word: captopril
  source: ''
  identifier: ''
- word: TXA
  source: MESH
  identifier: D014148
diseases:
- word: SARS-COV-2
  source: MESH
  identifier: D045169
figid_alias: PMC7198187__F1
redirect_from: /figures/PMC7198187__F1
figtype: Figure
---
